Executive Wealth Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$7.88M Buy
156,394
+95,800
+158% +$4.83M 0.62% 51
2024
Q3
$2.8M Buy
+60,594
New +$2.8M 0.22% 98
2024
Q2
Sell
-140,690
Closed -$3.62M 146
2024
Q1
$3.62M Buy
140,690
+115,690
+463% +$2.98M 0.32% 79
2023
Q4
$812K Hold
25,000
0.08% 124
2023
Q3
$681K Buy
+25,000
New +$681K 0.07% 129